本季度信息
华润医药旗下非全资子公司华润江中于2026年10月23日公布了截至2026年9月30日止九个月的未经审计财务业绩。报告期内，华润江中实现营业总收入约26.62亿元，同比下降9.25%；同期净利润约6.88亿元，同比下降7.32%。同期华润江中现金及现金等价物净减少约4.26亿元，期末现金及现金等价物余额约2.83亿元。
截至2026年9月30日，华润江中总资产达到约66.33亿元，负债总额约21.28亿元，所有者权益约45.05亿元。与2025年年末相比，主要资产和权益规模有所下降。由于上述财务数据仅限于华润江中，根据公告披露，并不能全面反映华润医药整体业务表现，敬请投资者关注并谨慎评估。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.